News


SRI biosciences wins $100 million for radiation research

 

One hundred million dollars over five years. That's how much the SRI International biosciences division is being awarded as part of a contract to research and develop products to address the effects of radiation exposure.

The multi-year contract was awarded by the National Institute of Allergy and Infectious Disease, part of the National Institutes of Health.

The principal investigator for the contract will be Polly Chang, senior director of molecular and genetic toxicology at SRI Biosciences. The award will support work related to developing medical "countermeasures" to address the effects of radiation and nuclear exposure.

SRI International is based in Menlo Park.

Kate Bradshaw

Comments

Sorry, but further commenting on this topic has been closed.

Ten Tips for Teens and Young Adults to Survive a Dysfunctional Family
By Chandrama Anderson | 2 comments | 1,556 views

UCSB's CCS program
By John Raftrey and Lori McCormick | 1 comment | 1,364 views

Farm Bill Passes Congress
By Laura Stec | 1 comment | 1,043 views

What is a Life?
By Aldis Petriceks | 0 comments | 725 views